Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 25:2022:8767137.
doi: 10.1155/2022/8767137. eCollection 2022.

The Clinical Efficacy of Platelet-Rich Plasma versus Conventional Drug Injection in the Treatment of Knee Osteoarthritis: A Study Protocol for a Randomized Controlled Trial

Affiliations

The Clinical Efficacy of Platelet-Rich Plasma versus Conventional Drug Injection in the Treatment of Knee Osteoarthritis: A Study Protocol for a Randomized Controlled Trial

Qi Ma et al. Evid Based Complement Alternat Med. .

Abstract

Knee osteoarthritis is a common chronic degenerative joint disease in middle-aged and elderly people. Intra-articular injection for the treatment of knee osteoarthritis is a regularly utilized nonsurgical treatment in modern medicine. Hyaluronic acid (HA) and platelet-rich plasma (PRP) are two frequently employed intra-articular devices. Hyaluronic acid (HA) is an accepted nonsurgical treatment for symptomatic KOA, and platelet-rich plasma is a popular option in the treatment of KOA in recent years. The purpose of this research is to compare the efficacy and safety of intra-articular injection of platelet-rich plasma (PRP) versus hyaluronic acid (HA) on the pain score scale, knee function, and related inflammatory biomarkers in KOA patients using a clinical randomized controlled trial. Participants are being randomized into either the hyaluronic acid (HA) or into the platelet-rich plasma (PRP) group. All patients receive 4 weeks of treatment (once a week), and well-being support and quadriceps training (3 times a week). The primary outcomes are measured using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and the visual analog scale (VAS). The secondary outcomes include the activities of daily living score, erythrocyte sedimentation rate, C-reactive protein testing, interleukin-6 levels, and X-ray examination. In order to monitor the occurrence of irregularities and abnormalities, patients are assessed at each visit, and restorative treatment is given if necessary. The results of this clinical trial will verify the efficacy of PRP and HA in the treatment of KOA and provide important evidence for the clinical treatment of KOA. The trial was enlisted at the Chinese Clinical Trial Registry on 26 September 2020 (ChiCTR2000038635).

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
The planned flowchart of the trail. PRP: platelet-rich plasma; HA: hyaluronic acid; HE: health education; QT: quadriceps femoral training; VAS: Visual Analogue Scale; WOMAC: Western Ontario and McMaster University Bone joint Index; ADL: activity of daily living score; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; IL-6: interleukin-6; X-ray: X-ray examination.

References

    1. Goldman L. H., Tang K., Facchetti L., et al. Role of thigh muscle cross-sectional area and strength in progression of knee cartilage degeneration over 48 months - data from the Osteoarthritis Initiative. Osteoarthritis and Cartilage . 2016;24(12):2082–2091. doi: 10.1016/j.joca.2016.07.004. - DOI - PMC - PubMed
    1. Cross M., Smith E., Hoy D., et al. The global burden of hip and knee osteoarthritis: estimates from the Global Burden of Disease 2010 study. Annals of the Rheumatic Diseases . 2014;73(7):1323–1330. doi: 10.1136/annrheumdis-2013-204763. - DOI - PubMed
    1. Deshpande B. R., Katz J. N., Solomon D. H., et al. Number of persons with symptomatic knee osteoarthritis in the US: impact of race and ethnicity, age, sex, and obesity. Arthritis Care & Research . 2016;68(12):1743–1750. doi: 10.1002/acr.22897. - DOI - PMC - PubMed
    1. Bijlsma J. W., Berenbaum F., Lafeber F. P. Osteoarthritis: an update with relevance for clinical practice. The Lancet . 2011;377(9783):2115–2126. doi: 10.1016/S0140-6736(11)60243-2. - DOI - PubMed
    1. Youm J., Chan V., Belkora J., Bozic K. J. Impact of socioeconomic factors on informed decision making and treatment choice in patients with hip and knee OA. The Journal of Arthroplasty . 2015;30(2):171–175. doi: 10.1016/j.arth.2014.09.006. - DOI - PubMed